Yıl: 2021 Cilt: 27 Sayı: Özel Sayı 1 Sayfa Aralığı: 6 - 8 Metin Dili: İngilizce DOI: 10.4274/tnd.2021.92891 İndeks Tarihi: 19-01-2022

Neurological Spectrum of COVID-19: A Practical Review

Öz:
Coronavirus disease-2019 (COVID-19) can be associated with wide-range neurologic symptoms and complications. Parainfectious manifestations that are seen during the active infection period include stroke, olfactory and taste disturbance, encephalopathy, encephalitis, neuropathies, and myopathies. The main postinfectious complications are acute disseminated encephalomyelitis, transverse myelitis, Guillain-Barré syndrome, cognitive disorders, and sleep disorders. COVID-19 commonly causes neurological mid-to-long-term disability. The disease prognosis can be improved with sufficient knowledge, prompt recognition, and effective management of neurological complications.
Anahtar Kelime:

COVID-19’un Nörolojik Görünümü: Pratiğe Yönelik Gözden Geçirme

Öz:
Koronavirüs hastalığı-2019 (COVID-19) çok farklı nörolojk semptom ve komplikasyonlarla birlikte olabilir. Aktif enfeksiyon döneminde görülen paraenfeksiyöz manifestasyonlar inme, koku ve tat bozukluğu, ensefalopati ve ensefalit ile nöropati ve miyopatileri içerir. Postenfeksiyöz komplikasyonların başlıcaları akut dissemine ensefalomiyelit, transvers miyelit ve Guillain-Barré sendromu, kognitif bozukluklar ve uyku bozukluklarıdır. COVID 19’un uzun dönemde nörolojik disabiliteye yol açması nadir değildir. Nörolojik komplikasyonların yeterince bilinmesi, zamanında tanınması ve etkili yönetimi ile hastalık prognozu iyileştirilebilir.
Anahtar Kelime:

Belge Türü: Makale Makale Türü: Derleme Erişim Türü: Erişime Açık
0
1
1
  • 1. WorldMeter. Daily New Cases in Turkey. Last Accessed Date: 31.10.2021. Available from: https://wwwworldometersinfo/coronavirus/country/turkey/
  • 2. Acar T, Demirel EA, Afşar N, et al. The COVID-19 from neurological overview. Turk J Neurol 2020;26:56-106.
  • 3. Ozturk S. The COVID-19 from neurological overview. Turk J Neurol 2020;26:56-57.
  • 4. Mengi T, Şirin H, Yaka E, et al. Brain death diagnosis and management in the pandemic: expert opinion of the Turkish Neurological Society Neurological Intensive Care Scientific Working Group. Turk J Neurol 2021;27.
  • 5. Frontera JA, Sabadia S, Lalchan R, et al. A prospective study of neurologic disorders in hospitalized patients with COVID-19 in New York City. Neurology 2021;96:e575-e586.
  • 6. Nath A. neurologic manifestations of severe acute respiratory syndrome coronavirus 2 infection. Continuum (Minneap Minn) 2021;27:1051-1065.
  • 7. Balcom EF, Nath A, Power C. Acute and chronic neurological disorders in COVID-19: potential mechanisms of disease. Brain 2021;awab302.
  • 8. Karadas O, Ozturk B, Sonkaya AR. A prospective clinical study of detailed neurological manifestations in patients with COVID-19. Neurol Sci 2020;41:1991-1995.
  • 9. Topcuoglu MA, Pektezel MY, Oge DD, et al. Stroke mechanism in COVID-19 infection: a prospective case-control study. J Stroke Cerebrovasc Dis 2021;30:105919.
  • 10. Misra S, Kolappa K, Prasad M, et al. Frequency of neurologic manifestations in COVID-19: a systematic review and meta-analysis. Neurology 2021;97:e2269-e2281.
  • 11. Topçuoğlu MA, Arsava EM, Özdemir AÖ. Acute ischemic stroke treatment in covid-19 pandemia: expert opinion. Turk J Cerebrovasc Dis 2020:91-94.
  • 12. Altunışık E, Arık A. Decreased stroke applications during pandemic: collateral effects of COVID-19. Turk J Neurol 2021;27:171-175.
  • 13. Ozturk S. COVID-19 and stroke: a neurological perspective. In: Dehkharghani S (ed). Brisbane: Stroke, 2021.
  • 14. Matschke J, Lutgehetmann M, Hagel C, et al. Neuropathology of patients with COVID - 19 in Germany: a post-mortem case series. Lancet Neurol 2020;19:919-929.
  • 15. Kirschenbaum D, Imbach LL, Rushing EJ, et al. Intracerebral endotheliitis and microbleeds are neuropathological features of COVID-19. Neuropathol Appl Neurobiol 2021;47:454-459.
  • 16. Poyiadji N, Shahin G, Noujaim D, et al. COVID-19-associated acute hemorrhagic necrotizing encephalopathy: imaging features. radiology 2020;296:E119-E120.
  • 17. Varadan B, Shankar A, Rajakumar A, et al. Acute hemorrhagic leukoencephalitis in a COVID-19 patient-a case report with literature review. Neuroradiology 2021;63:653-661.
  • 18. Manzano GS, McEntire CRS, Martinez-Lage M, Mateen FJ, Hutto SK. Acute disseminated encephalomyelitis and acute hemorrhagic leukoencephalitis following COVID-19: systematic review and meta-synthesis. Neurol Neuroimmunol Neuroinflamm 2021;8:e1080.
  • 19. Wang Y, Wang Y, Huo L, et al. SARS-CoV-2-associated acute disseminated encephalomyelitis: a systematic review of the literature. J Neurol 2021;1-22.
  • 20. Garg RK, Paliwal VK, Gupta A. Spinal cord involvement in COVID-19: a review. J Spinal Cord Med 2021:1-15.
  • 21. Palaiodimou L, Stefanou MI, Katsanos AH, F, et al. Prevalence, clinical characteristics and outcomes of Guillain-Barre syndrome spectrum associated with COVID-19: a systematic review and meta-analysis. Eur J Neurol 2021;28:3517-3529.
  • 22. Barda N, Dagan N, Ben-Shlomo Y, et al. Safety of the BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Setting. N Engl J Med 2021;385:1078- 1090.
  • 23. Palaiodimou L, Stefanou MI, Katsanos AH, et al. Cerebral venous sinus thrombosis and thrombotic events after vector-based COVID-19 vaccines: a systematic review and meta-analysis. Neurology 2021;97:e2136-e2147.
  • 24. Warkentin T, Cuker A. COVID-19: Vaccine-induced immune thrombotic thrombocytopenia (VITT). Up-to-Date 2021. Last Accessed Date: 01.11.2021. Available from: https://www.uptodate.com/contents/covid-19- vaccine-induced-immune-thrombotic-thrombocytopenia-vitt
APA TOPCUOGLU M, Ozturk S (2021). Neurological Spectrum of COVID-19: A Practical Review. , 6 - 8. 10.4274/tnd.2021.92891
Chicago TOPCUOGLU MEHMET,Ozturk Serefnur Neurological Spectrum of COVID-19: A Practical Review. (2021): 6 - 8. 10.4274/tnd.2021.92891
MLA TOPCUOGLU MEHMET,Ozturk Serefnur Neurological Spectrum of COVID-19: A Practical Review. , 2021, ss.6 - 8. 10.4274/tnd.2021.92891
AMA TOPCUOGLU M,Ozturk S Neurological Spectrum of COVID-19: A Practical Review. . 2021; 6 - 8. 10.4274/tnd.2021.92891
Vancouver TOPCUOGLU M,Ozturk S Neurological Spectrum of COVID-19: A Practical Review. . 2021; 6 - 8. 10.4274/tnd.2021.92891
IEEE TOPCUOGLU M,Ozturk S "Neurological Spectrum of COVID-19: A Practical Review." , ss.6 - 8, 2021. 10.4274/tnd.2021.92891
ISNAD TOPCUOGLU, MEHMET - Ozturk, Serefnur. "Neurological Spectrum of COVID-19: A Practical Review". (2021), 6-8. https://doi.org/10.4274/tnd.2021.92891
APA TOPCUOGLU M, Ozturk S (2021). Neurological Spectrum of COVID-19: A Practical Review. Türk Nöroloji Dergisi, 27(Özel Sayı 1), 6 - 8. 10.4274/tnd.2021.92891
Chicago TOPCUOGLU MEHMET,Ozturk Serefnur Neurological Spectrum of COVID-19: A Practical Review. Türk Nöroloji Dergisi 27, no.Özel Sayı 1 (2021): 6 - 8. 10.4274/tnd.2021.92891
MLA TOPCUOGLU MEHMET,Ozturk Serefnur Neurological Spectrum of COVID-19: A Practical Review. Türk Nöroloji Dergisi, vol.27, no.Özel Sayı 1, 2021, ss.6 - 8. 10.4274/tnd.2021.92891
AMA TOPCUOGLU M,Ozturk S Neurological Spectrum of COVID-19: A Practical Review. Türk Nöroloji Dergisi. 2021; 27(Özel Sayı 1): 6 - 8. 10.4274/tnd.2021.92891
Vancouver TOPCUOGLU M,Ozturk S Neurological Spectrum of COVID-19: A Practical Review. Türk Nöroloji Dergisi. 2021; 27(Özel Sayı 1): 6 - 8. 10.4274/tnd.2021.92891
IEEE TOPCUOGLU M,Ozturk S "Neurological Spectrum of COVID-19: A Practical Review." Türk Nöroloji Dergisi, 27, ss.6 - 8, 2021. 10.4274/tnd.2021.92891
ISNAD TOPCUOGLU, MEHMET - Ozturk, Serefnur. "Neurological Spectrum of COVID-19: A Practical Review". Türk Nöroloji Dergisi 27/Özel Sayı 1 (2021), 6-8. https://doi.org/10.4274/tnd.2021.92891